Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cancer Research Technology claims novel Wnt signaling inhibitors

May 4, 2010

Provectus reports on end-of-phase II meeting with FDA for PV-10

May 3, 2010

Pieris reports preclinical data for its c-Met Anticalin drug

May 3, 2010

Cleveland Biolabs describes novel curaxin radiosensitizers for cancer

May 3, 2010

Polo-like kinase 1 inhibitors from Cyclacel active in xenograft cancer models

May 3, 2010

Janus kinase inhibitors for cancer therapy claimed by Rigel Pharmaceuticals

May 3, 2010

Array BioPharma discloses novel receptor tyrosine kinase inhibitors

May 3, 2010

Hana Biosciences completes pre-NDA meeting with FDA for Marqibo

April 30, 2010

NexMed's NexACT technology improves delivery and activity of Angstrom's A6 anticancer compound

April 30, 2010

Tarceva receives E.U. approval as maintenance treatment in advanced NSCLC

April 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...